We are live on ! Find out more
CIC

Cornercap Investment Counsel Portfolio holdings

AUM $203M
1-Year Est. Return 17.67%
This Fund
S&P 500
This Quarter Est. Return
+7.64%
1 Year Est. Return
+17.67%
3 Year Est. Return
+55.44%
5 Year Est. Return
+79.88%
10 Year Est. Return
+193.02%
AUM
$649M
AUM Growth
+$38.4M
Cap. Flow
+$1.52M
Cap. Flow %
0.23%
Top 10 Hldgs %
8.38%
Holding
684
New
103
Increased
174
Reduced
151
Closed
77

Top Buys

Rank Stock Value
1
AMAT icon
Applied Materials
AMAT
+$2.43M
2
LMT icon
Lockheed Martin
LMT
+$2.07M
3
WFC icon
Wells Fargo
WFC
+$2.06M
4
SPGI icon
S&P Global
SPGI
+$2.04M
5
TFC icon
Truist Financial
TFC
+$1.8M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$2.6M
2
PH icon
Parker-Hannifin
PH
+$2.49M
3
AVGO icon
Broadcom
AVGO
+$2.4M
4
AXP icon
American Express
AXP
+$2.36M
5
CB icon
Chubb
CB
+$2.07M

Sector Composition

Rank Sector Weight
1 Financials 18.76%
2 Technology 17.7%
3 Healthcare 14.05%
4 Industrials 12.92%
5 Consumer Discretionary 8.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SBUX icon
551
Starbucks
SBUX
$119B
$230K 0.04%
2,521
– –
LOW icon
552
Lowe's Companies
LOW
$123B
$228K 0.04%
897
-85
-9% -$19.5K
IBTX
553
DELISTED
Independent Bank Group, Inc.
IBTX
$224K 0.03%
+4,904
New +$229K
LYEL icon
554
Lyell Immunopharma
LYEL
$351M
$217K 0.03%
4,856
– –
REPL icon
555
Replimune Group
REPL
$1.15B
$216K 0.03%
26,493
– –
VYGR icon
556
Voyager Therapeutics
VYGR
$195M
$216K 0.03%
23,217
– –
IPSC icon
557
Century Therapeutics
IPSC
$357M
$215K 0.03%
51,520
– –
BCAB icon
558
BioAtla
BCAB
$5.76M
$211K 0.03%
1,224
– –
LENZ
559
LENZ Therapeutics
LENZ
$168M
$209K 0.03%
9,350
-12
-0.1% -$249
SAGE
560
DELISTED
Sage Therapeutics
SAGE
$207K 0.03%
11,048
– –
LONA
561
LeonaBio Inc
LONA
$70.5M
$207K 0.03%
7,539
– –
PRME icon
562
Prime Medicine
PRME
$571M
$205K 0.03%
+29,241
New +$222K
STRO icon
563
Sutro Biopharma
STRO
$423M
$202K 0.03%
3,569
– –
ALDX icon
564
Aldeyra Therapeutics
ALDX
$91.1M
$201K 0.03%
61,601
– –
EXP icon
565
Eagle Materials
EXP
$6.47B
$200K 0.03%
+737
New +$174K
ZNTL icon
566
Zentalis Pharmaceuticals
ZNTL
$297M
$198K 0.03%
+12,582
New +$173K
GRTS
567
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$197K 0.03%
76,811
– –
HLF icon
568
Herbalife
HLF
$1.21B
$195K 0.03%
19,416
– –
CPRX
569
DELISTED
Catalyst Pharmaceutical
CPRX
$195K 0.03%
12,216
-1,171
-9% -$17.6K
MGTX icon
570
MeiraGTx Holdings
MGTX
$1.21B
$194K 0.03%
31,962
-121
-0.4% -$764
RLAY icon
571
Relay Therapeutics
RLAY
$4.37B
$192K 0.03%
23,088
– –
TRDA icon
572
Entrada Therapeutics
TRDA
$271M
$186K 0.03%
+13,143
New +$186K
CRBU icon
573
Caribou Biosciences
CRBU
$165M
$184K 0.03%
+35,754
New +$220K
ITOS
574
DELISTED
iTeos Therapeutics
ITOS
$181K 0.03%
13,240
– –
CTMX icon
575
CytomX Therapeutics
CTMX
$750M
$177K 0.03%
81,352
– –
21 22
23
24 25

Similar funds

NWM
NRI Wealth Management Santa Clara, California $196M AUM 32.41% 1-Year Est. Return
EECFX
EnCap Energy Capital Fund X Houston, Texas $216M AUM 11.92% 1-Year Est. Return
PSB
Passumpsic Savings Bank St. Johnsbury, Vermont $183M AUM
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
NMG
New Millennium Group Sandy, Utah $231M AUM 33.06% 1-Year Est. Return
EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
BC
Bowman & Company Oshkosh, Wisconsin $237M AUM 16.16% 1-Year Est. Return
EFA
Edge Financial Advisors Wheaton, Illinois $238M AUM 17.31% 1-Year Est. Return

Cornercap Investment Counsel's Q1 2024 Portfolio in Review

As of Q1 2024, Cornercap Investment Counsel held 684 positions worth $649M, up 6.3% from $611M the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.

Cornercap Investment Counsel's Q1 2024 filing shows 103 new, 174 increased, 151 reduced and 77 closed positions. Its largest new stake was Lockheed Martin: 4,734 shares worth $2.15M. The largest sale was CVS Health, an estimated $2.6M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Technology and Healthcare.

  • Cornercap Investment Counsel's largest Q1 2024 buy was Lockheed Martin: 4,734 shares worth $2.15M.
  • Cornercap Investment Counsel added most to Applied Materials in Q1 2024, an estimated $2.43M increase.
  • Cornercap Investment Counsel's biggest Q1 2024 reduction was Broadcom, cutting an estimated $2.4M.
  • Cornercap Investment Counsel fully exited CVS Health in Q1 2024, selling an estimated $2.6M.
  • Cornercap Investment Counsel's ten largest holdings make up 8.4% of its $649M portfolio in Q1 2024.
  • Cornercap Investment Counsel opened 103 new positions and closed 77 in Q1 2024.
  • Cornercap Investment Counsel's portfolio value rose 6.3% quarter-over-quarter to $649M.

Based on Cornercap Investment Counsel's 13F filing for Q1 2024, filed 10 May 2024.